Loading company…
Psylo develops psychedelic-inspired medicines for mental illness, including shorter-acting versions of psilocybin.
Psylo develops psychedelic-inspired medicines for mental illness and is working on a shorter-acting version of psilocybin. The company is based in Sydney, Australia, and was founded in 2021. Its Chief Scientific Officer, Samuel Banister, formerly led medicinal chemistry at the University of Sydney’s Brain and Mind Centre.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in